Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : YEEHAW CANDIDATES -- Ignore unavailable to you. Want to Upgrade?

To: Crossy who wrote (933)	1/8/2003 7:54:41 PM
From: JoeinIowa	Read Replies (2) \| Respond to of 23958

Crossy, I also like a stock with a good story. They typically do not have much in fundamentals but something that may happen in the future. Typically biotechs. Right now ALT fits this bill. Ken believes they won't get above the 200 dma which is probably true and so that is his trade. I am waiting to read their presentation they are giving tomorrow to see if we get any hints on how their current phase II trials are going. I've been doing some reading in their area of research and it looks very interesting to say to least. Anti-aging drugs. Who wouldn't be interested in those if they worked. Its the fountain of youth(nice story). Joe

To: Crossy who wrote (933)	1/8/2003 9:09:04 PM
From: Crossy	Read Replies (1) \| Respond to of 23958

re: MPOW.OB important strategic transcations completed today.. Company sold 35% of their customers (public info) but more than 50% of their operating costs (I concluded this by some inference) Rumor has it that they obtained at least $35m in the transaction. Plus they obtained a commitement for an A/R securitization line of $7.5m. If true this means they added book value in the transaction. After this transaction I see MPOW.OB to be EBITDA positive on a going-forward basis.. stay tuned rgrds CROSSY